Amyloid, tau and FDG PET imaging in Alzheimer's disease

Amyloid, tau and FDG PET imaging in Alzheimer's disease - PET imaging in Alzheimer's disease

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000054605

Enrollment

Registered

2025-01-01

Start date

2023-06-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

AD continuum

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Subjects who may be in the AD continuum

Exclusion criteria

Exclusion criteria: Subjects who may be in pregnancy Subjects who may be in unstable medical condition Subjects who are considered to be inappropriate by PI

Design outcomes

Primary

Measure	Time frame
The relationship between tau accumulation and clinical symptoms	—

Countries

Japan

Contacts

Public ContactHiroko Sato

Tokyo Metropolitan Institute for Geriatrics and Gerontology Research Team for Neuroimaging

sato@pet.tmig.or.jp03-3964-3241

Outcome results